2) Grillo-LOpez, A.J., White, C.A., Varns, C., et al.: Overview of the clinical development of rituxi-mab: first monoclonal antibody approved for the treatment of lymphoma. Semin. Oncol. 26 (5 Suppl. 14): 66-73, 1999.
3) Rosenberg, S.A., Lotze, M.T., Muul, L.M., et al.: Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl. J. Med. 313 (23): 1485-1492, 1985.